In Philadelphia, biodegradable pregnancy test startup Lia Diagnostics has raised $2.6 million in private funding.
The company, which says its paper-based tests are flushable, did not report sales in 2018 but received FDA approval in December 2017 for over-the-counter sales.
CEO Bethany Edwards declined to disclose the identity of the investors to Philadelphia’s The Inquirer, but a filing with the SEC shows the company is looking for an additional $400,000.
The company also raised about $50,000 by winning a startup pitch event at Berlin’s TechCrunch Disrupt.
Home pregnancy tests result in 2 million pounds of plastic being dumped into US landfills annually.